| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,028 |
2,471 |
$272K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,066 |
1,839 |
$211K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,558 |
2,227 |
$192K |
| 20610 |
|
1,745 |
1,368 |
$92K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,378 |
1,110 |
$23K |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
347 |
305 |
$5K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
500 |
398 |
$5K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,100 |
932 |
$4K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
121 |
117 |
$1K |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
66 |
66 |
$948.87 |
| 97750 |
|
68 |
51 |
$706.33 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
81 |
81 |
$551.18 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
383 |
318 |
$479.74 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
71 |
44 |
$344.32 |
| 1006F |
|
156 |
143 |
$148.55 |
| J3490 |
Unclassified drugs |
13 |
13 |
$0.00 |